Empowered Funds’s NEVRO CORP. NVRO Stock Holding History

Empowered Funds’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9,975	Closed	-$1.19M	–	161
2020 Q2	$1.19M	Buy	+9,975	New	+$1.18M	0.46%	93

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Empowered Funds's NVRO Position: Q3 2020 in Review

Empowered Funds sold out of NEVRO CORP. (NVRO) in Q3 2020, closing a stake of 9,975 shares — an estimated $1.19M sold.

Empowered Funds first reported a position in NVRO in Q2 2020 and held it in 1 quarter. The position peaked at $1.19M in Q2 2020. 210 funds tracked by Wall St. Rank hold NVRO as of Q3 2020.

Empowered Funds reported no remaining NEVRO CORP. position as of Q3 2020 after selling out during the quarter.
Empowered Funds sold 9,975 NEVRO CORP. shares in Q3 2020, an estimated $1.19M.
Empowered Funds first reported a position in NEVRO CORP. in Q2 2020 and held it in 1 quarter.
Empowered Funds's NEVRO CORP. position peaked at $1.19M in Q2 2020.
210 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2020.

Based on Empowered Funds's 13F filing for Q3 2020, filed 26 Oct 2020.